Trimurthi Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
13,284.10
2,179.50
30,754.60
5,934.20
3,517.40
Total Accounts Receivable
8,471.70
92,323.30
65,627.70
76,900.90
73,888.90
Inventories
6,417.90
4,501.20
4,577.30
10,012.90
8,627.40
Other Current Assets
79,031.60
5,170.70
13,429.20
17,460.30
19,599.80
Total Current Assets
107,205.30
104,174.70
114,388.70
110,308.30
105,633.50
Net Property, Plant & Equipment
7,374.30
5,290.60
9,283.10
20,644.80
21,538.90
Total Investments and Advances
2,551.60
13,429.50
500.00
3,284.00
6,320.50
Long-Term Note Receivable
-
-
321.10
751.80
-
Intangible Assets
4,341.20
2,236.90
327.60
324.40
168.90
Other Assets
269.60
-
2,530.20
2,151.60
2,136.20
Total Assets
121,741.90
125,131.80
127,350.70
137,465.00
135,798.00
ST Debt & Current Portion LT Debt
302.00
-
-
340.00
-
Accounts Payable
451.90
4,786.50
3,697.90
5,704.20
8,040.70
Income Tax Payable
2,228.70
1,638.80
1,735.50
-
-
Other Current Liabilities
929.60
830.50
1,096.10
2,111.80
1,416.10
Total Current Liabilities
3,912.20
7,255.80
6,529.40
8,156.00
9,456.80
Long-Term Debt
135.90
-
-
9,553.40
9,774.20
Deferred Taxes
1,159.60
831.80
238.30
706.50
835.00
Total Liabilities
5,207.70
8,087.60
6,767.80
18,415.90
20,065.90
Common Equity (Total)
114,484.20
114,289.90
115,511.30
115,401.50
111,667.50
Total Shareholders' Equity
114,484.20
114,289.90
115,511.30
115,401.50
111,667.50
Total Equity
116,534.20
117,044.10
120,583.00
119,049.10
115,732.00
Liabilities & Shareholders' Equity
121,741.90
125,131.80
127,350.70
137,465.00
135,798.00
Accumulated Minority Interest
2,050.00
2,754.30
5,071.70
3,647.60
4,064.60

About Trimurthi

View Profile
Address
4-4-231/1/2/ABC
Hyderabad TS 500095
India
Employees -
Website http://www.trimurthidrugs.com
Updated 09/14/2018
Trimurthi Ltd. operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.